(Q51981823)

English

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

scientific article published in August 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

0 references

1 reference

based on heuristic

inferred from title

quality of life

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Charles M. Beasley

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

author name string

D A Revicki

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

L A Genduso

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

S H Hamilton

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

D Ganoczy

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

publication date

1 August 1999

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

Quality of Life Research

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

8

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

417-426

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

https://scigraph.springernature.com/pub.10.1023/a:1008958925848

0 references

Quality of life of seriously mentally ill persons in Mississippi.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methodologic standards for treatment outcome research in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subjective response to antipsychotic drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conventional antipsychotic medications for schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Convergent validation of quality of life assessments for persons with severe mental illnesses.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients' subjective experiences on antipsychotic medications: implications for outcome and quality of life

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new patient focused index for measuring quality of life in persons with severe and persistent mental illness.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for drug-induced akathisia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A conceptual model of quality of life in schizophrenia: description and preliminary clinical validation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The quality of life of chronic patients in a state hospital and in community residences.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychopharmacologic treatment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preferences for schizophrenia-related health states: a comparison of patients, caregivers and psychiatrists.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clozapine's effectiveness for patients in state hospitals: results from a randomized trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Subjective response to neuroleptics in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Does capitation affect the health of the chronically mentally ill? Results from a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The well-being of chronic mental patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Using health status measures with the seriously mentally ill in health services research.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic mental patients: the quality of life issue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anchoring the BPRS: an aid to improved reliability

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of therapeutic response in schizophrenia. A critical survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A rating scale for extrapyramidal side effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measuring quality of life in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methods of pharmacoeconomic evaluation of psychopharmacologic therapies for patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic schizophrenics in the community: are they able to report their social adjustment?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10474283

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1008958925848

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/10474283

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51981823&oldid=1531340640"